Kolosis BIO Announces the Appointment of Michelle Soleimani-Mafi as Director of Operations
Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Michelle Soleimani-Mafi as its Director of Operations.
Kolosis BIO Announces 2021 Results
Kolosis BIO, LLC (Kolosis), a pure-play orthobiologics company and an exclusive partner to MTF Biologics, announced today its 2021 results and 2022 expectations.
Kolosis BIO Announces Relocation of its Headquarters to Historic Salt Lake Building
Salt Lake City, Utah, – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the relocation of its global headquarters to the historic Seed Building in downtown Salt Lake City.
Kolosis BIO to Exhibit at the 2022 Montana Orthopedic Society Meeting
Kolosis BIO, a privately-held pure-play orthobiologics company, announces its support of the 2022 Montana Orthopedic Society meeting, January 14-16 at the Yellowstone Conference Center in Big Sky, Montana.
Kolosis BIO Announces Release of Scientific White Paper
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the completion and release of a scientific white paper studying the effects of terminal sterilization on allograft tissues.
Kolosis BIO to Exhibit at the 2021 Society of Military Orthopedic Surgeons
Salt Lake City, Utah. – Kolosis BIO, a privately-held pure-play orthobiologics company, announces its support of the 2021 Society of Military Orthopedic Surgeons, December 14-17 at the Resort at Squaw Creek in Olympic Valley, California.
Kolosis BIO Appoints Maxwell Hunter as its Chief Operations Officer
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Maxwell Hunter as the company’s Chief Operating Officer.
Kolosis BIO Announces the Appointment of Keegan Begley as President
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Keegan Begley as the company’s President.
Kolosis BIO and MTF Biologics Announce Launch of Kore Fiber™
SALT LAKE CITY, Utah–(BUSINESS WIRE)—Kolosis BIO, LLC (Kolosis) announced today, in collaboration with MTF Biologics (MTF), the market release of Kore Fiber™, an exclusively processed demineralized cortical fiber allograft for Kolosis.